DLB files Form 144 to sell 7,667 shares via option

Accepted by SEC EDGAR 07/01/2026 - 04:27 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DLB submitted a Form 144 notice reporting proposed sale of 7,667 shares of Common Stock via a stock option exercise to occur on 07/01/2026. The filing lists the transaction type as Stock Option Exercise and indicates cash proceeds. The filing also records three recent sales by the same person: 7,666; 7,666; and 4,688 shares on prior dates with corresponding gross proceeds shown.

Key Figures

Proposed shares to be sold: 7,667 shares Prior sale - 06/01/2026: 7,666 shares Prior sale - 05/05/2026: 7,666 shares +3 more

6 metrics

Proposed shares to be sold 7,667 shares Stock Option Exercise on 07/01/2026

Prior sale - 06/01/2026 7,666 shares Sale by John Couling on 06/01/2026; gross proceeds $426,419.72

Prior sale - 05/05/2026 7,666 shares Sale by John Couling on 05/05/2026; gross proceeds $441,209.73

Prior sale - 05/04/2026 4,688 shares Sale by John Couling on 05/04/2026; gross proceeds $274,083.92

Line amount shown $407,894.37 Value appearing in the Securities Information line in the excerpt

Identifier/large number shown 60,346,214 Numeric string present in the securities information line

Key Terms

Form 144, Stock Option Exercise, Cash

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 07/01/2026 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Cash financial

"07/01/2026 | Stock Option Exercise | Issuer | | | 7667 | 07/01/2026 | Cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does DLB's Form 144 report about the upcoming sale?

It reports a proposed sale of 7,667 shares via a stock option exercise dated 07/01/2026. The notice lists the sale method as Stock Option Exercise and indicates cash as the settlement method in the excerpt.

Who is shown as having sold shares recently in the excerpt for DLB?

The excerpt lists sales by John Couling of Common Stock on 06/01/2026, 05/05/2026, and 05/04/2026. Each sale row includes share counts and gross proceeds in the provided lines.

What share counts and proceeds are shown for the recent sales in the Form 144 excerpt?

Recent rows show sales of 7,666 shares with $426,419.72, 7,666 shares with $441,209.73, and 4,688 shares with $274,083.92. These figures appear in the 'Securities Sold During The Past 3 Months' section.

Does the excerpt show how proceeds are treated for the 07/01/2026 transaction?

The excerpt indicates the 07/01/2026 stock option exercise is settled in cash. The filing line lists the sale method as Stock Option Exercise and shows 'Cash' under the settlement column in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001894052
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOLBY LABORATORIES, INC.
SEC File Number	001-32431
Address of Issuer	1275 Market Street San Francisco CALIFORNIA 94103-1410
Phone	(415) 558-0200
Name of Person for Whose Account the Securities are To Be Sold	JOHN COULING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7667	407894.37	60346214	07/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2026	Stock Option Exercise	Issuer			7667	07/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	06/01/2026	7666	426419.72
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	05/05/2026	7666	441209.73
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	05/04/2026	4688	274083.92

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John David Couling
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)